Invariant chain-MHC class II complexes: always odd and never invariant.
作者信息
Cresswell Peter, Roche Paul A
机构信息
Department of Immunobiology and Howard Hughes Medical Institute, Yale University Medical School, New Haven, CT, USA.
Experimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
出版信息
Immunol Cell Biol. 2014 Jul;92(6):471-2. doi: 10.1038/icb.2014.36. Epub 2014 Apr 29.
Abstract
摘要
相似文献
1
Invariant chain-MHC class II complexes: always odd and never invariant.
Immunol Cell Biol. 2014 Jul;92(6):471-2. doi: 10.1038/icb.2014.36. Epub 2014 Apr 29.
2
The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules.
Immunol Cell Biol. 2014 Jul;92(6):553-6. doi: 10.1038/icb.2014.17. Epub 2014 Mar 18.
3
Structural insights into human MHC-II association with invariant chain.
Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2403031121. doi: 10.1073/pnas.2403031121. Epub 2024 Apr 30.
4
Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
Nature. 1990 Nov 1;348(6296):39-44. doi: 10.1038/348039a0.
5
Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
Eur J Immunol. 2016 Apr;46(4):834-45. doi: 10.1002/eji.201545942. Epub 2016 Jan 22.
6
Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Mol Cell Proteomics. 2012 Nov;11(11):1457-67. doi: 10.1074/mcp.M112.019232. Epub 2012 Aug 31.
7
HLA-DQA2 and HLA-DQB2 genes are specifically expressed in human Langerhans cells and encode a new HLA class II molecule.
J Immunol. 2012 Apr 15;188(8):3903-11. doi: 10.4049/jimmunol.1103048. Epub 2012 Mar 9.
8
The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
Hum Immunol. 1998 Oct;59(10):607-14. doi: 10.1016/s0198-8859(98)00058-5.
9
NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Immunogenetics. 2013 Oct;65(10):711-24. doi: 10.1007/s00251-013-0720-y. Epub 2013 Jul 31.
10
HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.
J Exp Med. 2000 Dec 18;192(12):1697-706. doi: 10.1084/jem.192.12.1697.
引用本文的文献
1
Chaperone-mediated MHC-I peptide exchange in antigen presentation.
IUCrJ. 2024 May 1;11(Pt 3):287-298. doi: 10.1107/S2052252524002768.
2
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway.
Int J Mol Sci. 2023 Apr 4;24(7):6736. doi: 10.3390/ijms24076736.
3
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.
Pharmaceutics. 2023 Mar 5;15(3):846. doi: 10.3390/pharmaceutics15030846.
4
The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers.
BMC Immunol. 2021 Aug 12;22(1):56. doi: 10.1186/s12865-021-00444-6.
5
HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY.
Mol Cell Proteomics. 2021;20:100089. doi: 10.1016/j.mcpro.2021.100089. Epub 2021 Apr 29.
6
The Antigen Processing and Presentation Machinery in Lymphatic Endothelial Cells.
Front Immunol. 2019 May 7;10:1033. doi: 10.3389/fimmu.2019.01033. eCollection 2019.
7
Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway.
Crit Rev Biochem Mol Biol. 2019 Apr;54(2):164-173. doi: 10.1080/10409238.2019.1610352. Epub 2019 May 14.
8
Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.
Immunogenetics. 2019 Mar;71(3):233-249. doi: 10.1007/s00251-018-1090-2. Epub 2018 Oct 30.
9
RNA-seq comparative analysis of Peking ducks spleen gene expression 24 h post-infected with duck plague virulent or attenuated virus.
Vet Res. 2017 Sep 13;48(1):47. doi: 10.1186/s13567-017-0456-z.
10
The Other Function: Class II-Restricted Antigen Presentation by B Cells.
Front Immunol. 2017 Mar 23;8:319. doi: 10.3389/fimmu.2017.00319. eCollection 2017.
本文引用的文献
1
The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules.
Immunol Cell Biol. 2014 Jul;92(6):553-6. doi: 10.1038/icb.2014.17. Epub 2014 Mar 18.
2
Pathways of antigen processing.
Annu Rev Immunol. 2013;31:443-73. doi: 10.1146/annurev-immunol-032712-095910. Epub 2013 Jan 3.
3
Stoichiometry of HLA class II-invariant chain oligomers.
PLoS One. 2011 Feb 22;6(2):e17257. doi: 10.1371/journal.pone.0017257.
4
Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.
J Cell Biol. 1996 Apr;133(2):281-91. doi: 10.1083/jcb.133.2.281.
5
Invariant chain structure and MHC class II function.
Cell. 1996 Feb 23;84(4):505-7. doi: 10.1016/s0092-8674(00)81025-9.
6
Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens.
J Cell Biol. 1990 Sep;111(3):839-55. doi: 10.1083/jcb.111.3.839.
7
Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.
Nature. 1991 Dec 5;354(6352):392-4. doi: 10.1038/354392a0.
8
Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
J Immunol. 1992 Jun 1;148(11):3478-82.
9
The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.
J Immunol. 1992 Apr 15;148(8):2586-90.
Zotero 插件